P

Passage Bio

99 employees

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Wellness

Date founded

2017

Funding rounds raised

Total raised

$116M

from 13 investors over 13 rounds

P

Passage Bio raised $110M on September 4, 2019

Investors: Lilly Asia Ventures, Versant Ventures, OrbiMed Advisors, Frazier Healthcare Partners, New Leaf Venture Partners, Vivo Capital and Sphera Fund

P

Passage Bio raised $116M on February 15, 2019

Investors: Lilly Asia Ventures, OrbiMed Advisors, Versant Ventures, Frazier Healthcare Partners, New Leaf Venture Partners and Vivo Capital

FAQ